FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

STANZIONE DANIEL
2. Issuer Name and Ticker or Trading Symbol

QUEST DIAGNOSTICS INC [ DGX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

500 PLAZA DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)

9/11/2017
(Street)

SECAUCUS, NJ 07094
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   9/11/2017     M    7316   A $51.55   41991   D    
Common Stock   9/11/2017     M    7319   A $55.76   49310   D    
Common Stock   9/11/2017     M    5592   A $57.665   54902   D    
Common Stock   9/11/2017     M    4268   A $57.565   59170   D    
Common Stock   9/11/2017     M    5221   A $61.225   64391   D    
Common Stock   9/11/2017     M    5592   A $57.565   69983   D    
Common Stock   9/11/2017     M    5592   A $61.225   75575   D    
Common Stock   9/11/2017     S    40900   D $108.067   34675   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy)   $51.55   9/11/2017     M   (1)       7316      (2) 5/14/2019   Common Stock   7316.0   $51.55   0   D    
Stock Options (Right to Buy)   $55.76   9/11/2017     M   (1)       7319      (3) 5/6/2020   Common Stock   7319.0   $55.76   0   D    
Stock Options (Right to Buy)   $57.665   9/11/2017     M   (1)       5592      (4) 5/17/2021   Common Stock   5592.0   $57.665   0   D    
Non-Qualifed Stock Option (right to buy)   $57.565   9/11/2017     M   (1)       5592      (5) 5/11/2022   Common Stock   5592.0   $57.565   0   D    
Stock Options (Right to Buy)   $57.565   9/11/2017     M   (1)       4268      (5) 5/11/2022   Common Stock   4268.0   $57.565   0   D    
Non-Qualifed Stock Option (right to buy)   $61.225   9/11/2017     M   (1)       5592      (6) 5/21/2023   Common Stock   5592.0   $61.225   0   D    
Stock Options (Right to Buy)   $61.225   9/11/2017     M   (1)       5221      (6) 5/21/2023   Common Stock   5221.0   $61.225   0   D    

Explanation of Responses:
(1)  This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 3, 2017.
(2)  The options vested in three annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.
(3)  The options vested in three annual installments beginning with the first on May 16, 2011, the second on May 6, 2012 and the final on May 6, 2013.
(4)  The options vested in three annual installments beginning with the first on May 17, 2012, the second on May 17, 2013 and the final on May 17, 2014.
(5)  The options vested in three annual installments beginning with the first on May 11, 2013, the second on May 11, 2014 and the final on May 11, 2015.
(6)  The options vested in three annual installments beginning with the first on May 21, 2014, the second on May 21, 2015 and the final on May 21, 2016.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
STANZIONE DANIEL
500 PLAZA DRIVE
SECAUCUS, NJ 07094
X



Signatures
/s/ William J. O'Shaughnessy, Jr., Attorney in Fact for Daniel Stanzione 9/13/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Quest Diagnostics (NYSE:DGX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Quest Diagnostics Charts.
Quest Diagnostics (NYSE:DGX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Quest Diagnostics Charts.